N-[(1,2,3,4-TETRAHYDRO-1-ISOQUINOLINE)METHYL]-BENZAMIDE
97%(HPLC)
- Product Code: 54402
CAS:
64411-74-1
| Molecular Weight: | 266.34 g./mol | Molecular Formula: | C₁₇H₁₈N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | 124-125℃ | Boiling Point: | 504.1±30.0℃(Predicted) |
| Density: | 1.118±0.06 g/cm3(Predicted) | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmacological research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological disorders. Its structural features make it a valuable scaffold for developing compounds with potential analgesic, anti-inflammatory, or neuroprotective properties. Researchers explore its derivatives to modulate specific receptors or enzymes in the central nervous system, aiming to create novel therapeutic agents for conditions like chronic pain, depression, or neurodegenerative diseases. Additionally, its unique chemical structure allows for further modifications to enhance bioavailability, selectivity, and efficacy in drug development pipelines.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.200 | 10-20 days | ฿9,000.00 |
+
-
|
N-[(1,2,3,4-TETRAHYDRO-1-ISOQUINOLINE)METHYL]-BENZAMIDE
This compound is primarily utilized in the field of medicinal chemistry and pharmacological research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological disorders. Its structural features make it a valuable scaffold for developing compounds with potential analgesic, anti-inflammatory, or neuroprotective properties. Researchers explore its derivatives to modulate specific receptors or enzymes in the central nervous system, aiming to create novel therapeutic agents for conditions like chronic pain, depression, or neurodegenerative diseases. Additionally, its unique chemical structure allows for further modifications to enhance bioavailability, selectivity, and efficacy in drug development pipelines.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :